175 related articles for article (PubMed ID: 36219564)
21. Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease.
George J; Singh S; Dulai PS; Ma C; Nguyen T; Feagan BG; Sandborn WJ; Jairath V
Inflamm Bowel Dis; 2020 Mar; 26(4):515-523. PubMed ID: 31504528
[TBL] [Abstract][Full Text] [Related]
22. Cannabis for the treatment of Crohn's disease.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
[TBL] [Abstract][Full Text] [Related]
23. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
24. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.
Shehab M; Alrashed F; Alkazemi A; Lakatos PL; Bessissow T
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):469-477. PubMed ID: 36961082
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187
[TBL] [Abstract][Full Text] [Related]
26. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease.
Ng SC; Lam YT; Tsoi KK; Chan FK; Sung JJ; Wu JC
Aliment Pharmacol Ther; 2013 Oct; 38(8):854-63. PubMed ID: 23981095
[TBL] [Abstract][Full Text] [Related]
27. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
[TBL] [Abstract][Full Text] [Related]
28. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
[TBL] [Abstract][Full Text] [Related]
29. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK; Wang JJ
Cochrane Database Syst Rev; 2010 Oct; (10):CD006774. PubMed ID: 20927749
[TBL] [Abstract][Full Text] [Related]
30. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials.
Ben-Horin S; Zhao Y; Guo J; Mao R; Novack L; Sergienko R; Zhang J; Kobayashi T; Hibi T; Chowers Y; Colombel JF; Peyrin-Biroulet L; Kaplan G; Chen MH
BMJ Open; 2019 Jan; 9(1):e024222. PubMed ID: 30782731
[TBL] [Abstract][Full Text] [Related]
33. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
34. Type I interferons for induction of remission in ulcerative colitis.
Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
[TBL] [Abstract][Full Text] [Related]
35. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Taylor K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
[TBL] [Abstract][Full Text] [Related]
36. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
Cholapranee A; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
[TBL] [Abstract][Full Text] [Related]
37. Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases.
Sieber A; Aberra FN; Bonhomme B; McKeever L; Lewis JD
Dig Dis Sci; 2022 Nov; 67(11):5168-5176. PubMed ID: 35094254
[TBL] [Abstract][Full Text] [Related]
38. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
[TBL] [Abstract][Full Text] [Related]
39. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
Jayasooriya N; Baillie S; Blackwell J; Bottle A; Petersen I; Creese H; Saxena S; Pollok RC;
Aliment Pharmacol Ther; 2023 Mar; 57(6):635-652. PubMed ID: 36627691
[TBL] [Abstract][Full Text] [Related]
40. Low dose naltrexone for induction of remission in Crohn's disease.
Segal D; Macdonald JK; Chande N
Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]